The Observer is a student-run, daily print & online newspaper serving Notre Dame, Saint Mary's & Holy Cross. Learn about us.
-2 posts tagged "MRSA"
Alex Cao | Thursday, February 19, 2015
A team of researches led by Professor Shahriar Mobashery and Mayland Chang developed an antibiotic to combat Methicillin-resistant Staphylococcus aureus, or MRSA, a strain of a certain species of bacteria that is resistant to a considerable number of conventional modern antibiotics. “MRSA is a multi-drug resistant version of a very common bacterium called staph aureus,”
Evelyn Huang | Thursday, March 20, 2014
Researchers at Notre Dame discovered a new class of antibiotics to fight disease-causing bacterium such as methicillin-resistant Staphylococcus aureus (MRSA). Dr. Mayland Chang and Dr. Shahriar Mobashery, both professors in the department of chemistry and biochemistry, spearheaded the research that led to the discovery of these new antibiotics, called oxadiazoles. Oxadiazoles are able to overcome